Bariatrics clinical trial - Celgene RPC01-3203

Bariatrics

Status:

Active and Enrolling

ClinicalTrials.gov:

NCT03464097

Celgene RPCO1 3203

Drug

Ozanimod/ Placebo

Phase

III

Condition

Chron's Disease